{
    "CLINICAL SIGNIFICANCE": {
        "Predictive / Therapeutic": {
            "Sensitive (in vitro)": [
                "FDA/EMA/Swissmedic approved therapy (Tier IA)",
                "Therapy included in Professional Guidelines such as NCCN or CAP (Tier IA)",
                "Well-powered studies with consensus from experts in the field (Tier IB)",
                "FDA/EMA/Swissmedic approved therapy for a different tumor type (Tier IIC)",
                "Small published studies with some consensus (Tier IIC)",
                "Population study (Tier IID)",
                "Clinical trial (Tier IID)",
                "Pre-clinical trial (Tier IID)",
                "Case reports (Tier IID)",
                "No convincing published evidence of drugs effect (Tier III)",
                "Reported evidence supportive of benign/likely benign effect (Tier IV)",
                "Other criteria"
            ],
            "Responsive": [
                "FDA/EMA/Swissmedic approved therapy (Tier IA)",
                "Therapy included in Professional Guidelines such as NCCN or CAP (Tier IA)",
                "Well-powered studies with consensus from experts in the field (Tier IB)",
                "FDA/EMA/Swissmedic approved therapy for a different tumor type (Tier IIC)",
                "Small published studies with some consensus (Tier IIC)",
                "Population study (Tier IID)",
                "Clinical trial (Tier IID)",
                "Pre-clinical trial (Tier IID)",
                "Case reports (Tier IID)",
                "No convincing published evidence of drugs effect (Tier III)",
                "Reported evidence supportive of benign/likely benign effect (Tier IV)",
                "Other criteria"
            ],
            "Resistant (in vitro)": [
                "FDA/EMA/Swissmedic approved therapy (Tier IA)",
                "Therapy included in Professional Guidelines such as NCCN or CAP (Tier IA)",
                "Well-powered studies with consensus from experts in the field (Tier IB)",
                "FDA/EMA/Swissmedic approved therapy for a different tumor type (Tier IIC)",
                "Small published studies with some consensus (Tier IIC)",
                "Population study (Tier IID)",
                "Clinical trial (Tier IID)",
                "Pre-clinical trial (Tier IID)",
                "Case reports (Tier IID)",
                "No convincing published evidence of drugs effect (Tier III)",
                "Reported evidence supportive of benign/likely benign effect (Tier IV)",
                "Other criteria"
            ],
            "Reduced sensitivity": [
                "FDA/EMA/Swissmedic approved therapy (Tier IA)",
                "Therapy included in Professional Guidelines such as NCCN or CAP (Tier IA)",
                "Well-powered studies with consensus from experts in the field (Tier IB)",
                "FDA/EMA/Swissmedic approved therapy for a different tumor type (Tier IIC)",
                "Small published studies with some consensus (Tier IIC)",
                "Population study (Tier IID)",
                "Clinical trial (Tier IID)",
                "Pre-clinical trial (Tier IID)",
                "Case reports (Tier IID)",
                "No convincing published evidence of drugs effect (Tier III)",
                "Reported evidence supportive of benign/likely benign effect (Tier IV)",
                "Other criteria"
            ],
            "Not responsive": [
                "FDA/EMA/Swissmedic approved therapy (Tier IA)",
                "Therapy included in Professional Guidelines such as NCCN or CAP (Tier IA)",
                "Well-powered studies with consensus from experts in the field (Tier IB)",
                "FDA/EMA/Swissmedic approved therapy for a different tumor type (Tier IIC)",
                "Small published studies with some consensus (Tier IIC)",
                "Population study (Tier IID)",
                "Clinical trial (Tier IID)",
                "Pre-clinical trial (Tier IID)",
                "Case reports (Tier IID)",
                "No convincing published evidence of drugs effect (Tier III)",
                "Reported evidence supportive of benign/likely benign effect (Tier IV)",
                "Other criteria"
            ],
            "Adverse response": [
                "FDA/EMA/Swissmedic approved therapy (Tier IA)",
                "Therapy included in Professional Guidelines such as NCCN or CAP (Tier IA)",
                "Well-powered studies with consensus from experts in the field (Tier IB)",
                "FDA/EMA/Swissmedic approved therapy for a different tumor type (Tier IIC)",
                "Small published studies with some consensus (Tier IIC)",
                "Population study (Tier IID)",
                "Clinical trial (Tier IID)",
                "Pre-clinical trial (Tier IID)",
                "Case reports (Tier IID)",
                "No convincing published evidence of drugs effect (Tier III)",
                "Reported evidence supportive of benign/likely benign effect (Tier IV)",
                "Other criteria"
            ],
            "Other": [
                "FDA/EMA/Swissmedic approved therapy (Tier IA)",
                "Therapy included in Professional Guidelines such as NCCN or CAP (Tier IA)",
                "Well-powered studies with consensus from experts in the field (Tier IB)",
                "FDA/EMA/Swissmedic approved therapy for a different tumor type (Tier IIC)",
                "Small published studies with some consensus (Tier IIC)",
                "Population study (Tier IID)",
                "Clinical trial (Tier IID)",
                "Pre-clinical trial (Tier IID)",
                "Case reports (Tier IID)",
                "No convincing published evidence of drugs effect (Tier III)",
                "Reported evidence supportive of benign/likely benign effect (Tier IV)",
                "Other criteria"
            ]
        },
        "Prognostic": {
            "Good outcome": [
                "Included in Professional Guidelines (Tier IA)",
                "Well-powered studies with consensus from experts in the field (Tier IB)",
                "Small published studies with some consensus (Tier IIC)",
                "Population study (Tier IID)",
                "Clinical trial (Tier IID)",
                "Pre-clinical trial (Tier IID)",
                "Case reports (Tier IID)",
                "No convincing published evidence of drugs effect (Tier III)",
                "Reported evidence supportive of benign/likely benign effect (Tier IV)",
                "Other criteria"
            ],
            "Poor outcome": [
                "Included in Professional Guidelines (Tier IA)",
                "Well-powered studies with consensus from experts in the field (Tier IB)",
                "Small published studies with some consensus (Tier IIC)",
                "Population study (Tier IID)",
                "Clinical trial (Tier IID)",
                "Pre-clinical trial (Tier IID)",
                "Case reports (Tier IID)",
                "No convincing published evidence of drugs effect (Tier III)",
                "Reported evidence supportive of benign/likely benign effect (Tier IV)",
                "Other criteria"
            ],
            "Intermediate": [
                "Included in Professional Guidelines (Tier IA)",
                "Well-powered studies with consensus from experts in the field (Tier IB)",
                "Small published studies with some consensus (Tier IIC)",
                "Population study (Tier IID)",
                "Clinical trial (Tier IID)",
                "Pre-clinical trial (Tier IID)",
                "Case reports (Tier IID)",
                "No convincing published evidence of drugs effect (Tier III)",
                "Reported evidence supportive of benign/likely benign effect (Tier IV)",
                "Other criteria"
            ]
        },
        "Diagnostic": {
            "Associated with diagnosis": [
                "Included in Professional Guidelines (Tier IA)",
                "Well-powered studies with consensus from experts in the field (Tier IB)",
                "Small published studies with some consensus (Tier IIC)",
                "Population study (Tier IID)",
                "Clinical trial (Tier IID)",
                "Pre-clinical trial (Tier IID)",
                "Case reports (Tier IID)",
                "No convincing published evidence of drugs effect (Tier III)",
                "Reported evidence supportive of benign/likely benign effect (Tier IV)",
                "Other criteria"
            ],
            "Not associated with diagnosis": [
                "Included in Professional Guidelines (Tier IA)",
                "Well-powered studies with consensus from experts in the field (Tier IB)",
                "Small published studies with some consensus (Tier IIC)",
                "Population study (Tier IID)",
                "Clinical trial (Tier IID)",
                "Pre-clinical trial (Tier IID)",
                "Case reports (Tier IID)",
                "No convincing published evidence of drugs effect (Tier III)",
                "Reported evidence supportive of benign/likely benign effect (Tier IV)",
                "Other criteria"
            ],
            "Other": [
                "Included in Professional Guidelines (Tier IA)",
                "Well-powered studies with consensus from experts in the field (Tier IB)",
                "Small published studies with some consensus (Tier IIC)",
                "Population study (Tier IID)",
                "Clinical trial (Tier IID)",
                "Pre-clinical trial (Tier IID)",
                "Case reports (Tier IID)",
                "No convincing published evidence of drugs effect (Tier III)",
                "Reported evidence supportive of benign/likely benign effect (Tier IV)",
                "Other criteria"
            ]
        },
        "Variant identification": {
            "Unknown": [
                "None"
            ]
        }
    },
    "BIOLOGICAL RELEVANCE": {
        "Function": {
            "Gain of function": [
                "Well-established in vitro study",
                "Well-established in vivo study ",
                "Prediction",
                "Author statement",
                "Other criteria"
            ],
            "Loss of function": [
                "Well-established in vitro study",
                "Well-established in vivo study ",
                "Prediction",
                "Author statement",
                "Other criteria"
            ],
            "Neomorphic": [
                "Well-established in vitro study",
                "Well-established in vivo study ",
                "Prediction",
                "Author statement",
                "Other criteria"
            ],
            "Unaltered function": [
                "Well-established in vitro study",
                "Well-established in vivo study ",
                "Prediction",
                "Author statement",
                "Other criteria"
            ],
            "Dominant negative": [
                "Well-established in vitro study",
                "Well-established in vivo study ",
                "Prediction",
                "Author statement",
                "Other criteria"
            ]
        },
        "Subcellular location": {
            "Loss of physiological location": [
                "Well-established in vitro study",
                "Well-established in vivo study ",
                "Prediction",
                "Author statement",
                "Other criteria"
            ],
            "Decreased physiological location": [
                "Well-established in vitro study",
                "Well-established in vivo study ",
                "Prediction",
                "Author statement",
                "Other criteria"
            ],
            "Increased physiological location": [
                "Well-established in vitro study",
                "Well-established in vivo study ",
                "Prediction",
                "Author statement",
                "Other criteria"
            ],
            "New location": [
                "Well-established in vitro study",
                "Well-established in vivo study ",
                "Prediction",
                "Author statement",
                "Other criteria"
            ],
            "Unaltered location": [
                "Well-established in vitro study",
                "Well-established in vivo study ",
                "Prediction",
                "Author statement",
                "Other criteria"
            ],
            "Other": [
                "Well-established in vitro study",
                "Well-established in vivo study ",
                "Prediction",
                "Author statement",
                "Other criteria"
            ]
        },
        "Interaction": {
            "Loss of interaction with known partner(s)": [
                "Well-established in vitro study",
                "Well-established in vivo study ",
                "Prediction",
                "Author statement",
                "Other criteria"
            ],
            "Decreased interaction with known partner(s)": [
                "Well-established in vitro study",
                "Well-established in vivo study ",
                "Prediction",
                "Author statement",
                "Other criteria"
            ],
            "Increased interaction with known partner(s)": [
                "Well-established in vitro study",
                "Well-established in vivo study ",
                "Prediction",
                "Author statement",
                "Other criteria"
            ],
            "New interaction partner(s)": [
                "Well-established in vitro study",
                "Well-established in vivo study ",
                "Prediction",
                "Author statement",
                "Other criteria"
            ],
            "Other": [
                "Well-established in vitro study",
                "Well-established in vivo study ",
                "Prediction",
                "Author statement",
                "Other criteria"
            ]
        },
        "Expression": {
            "Loss of expression": [
                "Well-established in vitro study",
                "Well-established in vivo study ",
                "Author statement",
                "Other criteria"
            ],
            "Decreased expression": [
                "Well-established in vitro study",
                "Well-established in vivo study ",
                "Author statement",
                "Other criteria"
            ],
            "Increased expression": [
                "Well-established in vitro study",
                "Well-established in vivo study ",
                "Author statement",
                "Other criteria"
            ],
            "Misexpression": [
                "Well-established in vitro study",
                "Well-established in vivo study ",
                "Author statement",
                "Other criteria"
            ],
            "Other": [
                "Well-established in vitro study",
                "Well-established in vivo study ",
                "Author statement",
                "Other criteria"
            ]
        },
        "Response to drug": {
            "Loss of drug response": [
                "Well-established in vitro study",
                "Well-established in vivo study ",
                "Prediction",
                "Author statement",
                "Other criteria"
            ],
            "Decreased drug response": [
                "Well-established in vitro study",
                "Well-established in vivo study ",
                "Prediction",
                "Author statement",
                "Other criteria"
            ],
            "Increased drug response": [
                "Well-established in vitro study",
                "Well-established in vivo study ",
                "Prediction",
                "Author statement",
                "Other criteria"
            ],
            "Newly acquired drug response": [
                "Well-established in vitro study",
                "Well-established in vivo study ",
                "Prediction",
                "Author statement",
                "Other criteria"
            ],
            "Other": [
                "Well-established in vitro study",
                "Well-established in vivo study ",
                "Prediction",
                "Author statement",
                "Other criteria"
            ]
        }
    }
}